Open an account

Nutex Health

NUTX · NASDAQ

$198.99+$7.74 (+4.05%)TodayMarket closed ·
Prev close $191.25

About NUTX

Nutex Health, Inc. engages in the management and operation of healthcare facilities. The company is headquartered in Houston, Texas and currently employs 944 full-time employees. The company went IPO on 2011-03-18. The firm operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

Employees
944
Headquarters
Houston, Texas
Listed
Mar 18, 2011
Sector
Health Care
Industry
Health Care Providers & Services
Website
nutexhealth.com

NUTX key statistics

Market cap
1.36B
Price-earnings ratio
7.57
Dividend yield
6.24%
Average volume
152.15K
Volume
102.89K
Open price
$189.45
High today
$200.00
Low today
$189.45
52 Week high
$226.16
52 Week low
$83.99

Nutex Health (NUTX) at a glance

Nutex Health (NUTX) last traded at $198.99, with a market cap of 1.36B, a price-to-earnings ratio of 7.57 and a dividend yield of 6.24%.

Today the stock has traded between $189.45 and $200.00. The current price is 5.0% above the day's low and 0.5% below its high.

Volume so far is 102.89K shares, below the average of 152.15K shares a day.

Over the past year Nutex Health has ranged from $83.99 to $226.16, and now sits 81% of the way up that range.

Nutex Health met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $9.38 per share against an estimate of $5.05.

The average analyst price target is $293.96, 47.7% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $293.96
Low
$202.00
Now
$198.99
High
$341.25

NUTX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 1932.7% on average.

  1. Q3 FY24: reported -$1.72 per share against an estimate of -$0.2448
  2. Q4 FY24: reported $11.12 per share against an estimate of -$0.1258
  3. Q1 FY25: reported $2.56 per share against an estimate of $2.34
  4. Q2 FY25: reported -$2.95 per share against an estimate of -$2.93
  5. Q3 FY25: reported $7.76 per share against an estimate of $1.11
  6. Q4 FY25: reported $1.73 per share against an estimate of $6.98
  7. Q1 FY26: reported $6.52 per share against an estimate of $4.98
  8. Q2 FY26: reported $9.38 per share against an estimate of $5.05

NUTX news

  • Press releasePRNewswire

    Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call

  • Press releasePRNewswire

    Nutex Health Approved for Dual Listing on Nasdaq Texas

  • Press releasePRNewswire

    NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT

  • Press releasePRNewswire

    Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data

  • Press releasePRNewswire

    Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026

  • Press releasePRNewswire

    Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act

  • Press releasePRNewswire

    NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS

  • Press releasePRNewswire

    NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Similar companies

Companies in the same industry as Nutex Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.